**Cancer Cases Projected to Nearly Double by 2050, WHO Warns**
The World Health Organization (WHO) has issued a stark warning regarding the future of cancer globally, projecting that new cancer cases will nearly double by the year 2050. In a report released on Wednesday, the agency highlighted that cancer is anticipated to affect more than 90% of the global population at some point in their lives, either through personal diagnosis or that of a close relative.
Currently, cancer is the second leading cause of death worldwide, following cardiovascular disease, with over 26,000 lives lost each day. The WHO estimates that there are nearly 10 million cancer-related deaths and 20.6 million new cases reported annually. Without immediate and effective intervention, these numbers are expected to rise dramatically, with new cases projected to reach 35 million by 2050.
The report indicates that one in five individuals will develop cancer during their lifetime, with lung cancer identified as the deadliest form of the disease. Despite advancements in treatment options, the likelihood of survival is increasingly influenced by geographic and socioeconomic factors. For instance, the five-year survival rate for breast and childhood cancers exceeds 85% in high-income countries, while in low-income nations, it plummets to below 45%.
The WHO's findings also reveal significant disparities in access to cancer care. Currently, 23 countries lack radiotherapy facilities, and two-thirds of nations do not include cancer care in their universal health coverage. The financial burden of cancer treatment is so severe that up to 90% of patients in certain regions are forced to abandon their care due to costs. Overall, at least 45% of cancer patients experience financial hardship, making cancer a leading cause of medical bankruptcy across the globe.
In light of these challenges, the WHO is calling on governments, international organizations, and the private sector to adopt a "people-centered" approach to cancer care. This includes integrating cancer services from prevention to diagnosis and treatment within universal health coverage frameworks, enhancing support for patients and caregivers, and fostering research and innovation to broaden access to treatment.
In response to the growing cancer crisis, numerous countries are actively developing vaccines aimed at combating the disease. Russia, for instance, is focusing on personalized mRNA cancer vaccines that are tailored to individual tumors. Two experimental therapies, Neooncovac for melanoma and Oncopept for colorectal cancer, received clearance for clinical use in March, with over 40 patients already enrolled in trials. Early results indicate a strong immune response among the first recipients, and these vaccines are expected to be provided free of charge under Russia's national health insurance system, pending confirmation of their clinical effectiveness.
Other nations, including the United States, United Kingdom, Cuba, and China, are also engaged in cancer vaccine development through various approved treatments, clinical trials, and personalized mRNA platforms.
As the global community grapples with the rising incidence of cancer, the WHO's report serves as a critical reminder of the need for comprehensive strategies to address both the medical and financial challenges posed by this disease. The call for a unified approach to cancer care and prevention is more urgent than ever, as the implications of inaction could be profound, affecting millions of lives worldwide.